Patients and methods: A preliminary diagnosis was made by qualitative detection of urinary glycosaminoglycans of the suspected MPS II probands. The IDS mutation and polymorphisms were determined on these probands and their family members by amplifying and sequencing each of the exons and intron-exon junctions of IDS gene.Results: The studied probands were homoallelic for p.R88P mutation. In addition, three known polymorphisms/sequence variants: IVS3-16 (c.419-16 delT), T214M (c.641C > T), T146T (c.438 C > T), IVS5-87(c.709-87G > A) and one previously unknown: IVS7+38(c.1006+38T > C were identified in the MPS II patients. These are the first Tunisian MPS II patients to be genotyped.Conclusion: The identification of these mutation and polymorphisms and their genotype-phenotype correlation should facilitate prenatal diagnosis and counseling for MPS II in Tunisia, where a very high rate of consanguinity exists. © 2011 Chkioua et al; licensee BioMed Central Ltd.
CITATION STYLE
Chkioua, L., Khedhiri, S., Ferchichi, S., Tcheng, R., Chahed, H., Froissart, R., … Miled, A. (2011). Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II. Diagnostic Pathology, 6(1). https://doi.org/10.1186/1746-1596-6-42
Mendeley helps you to discover research relevant for your work.